Skip to main content
Clinical Trials/NCT05076331
NCT05076331
Unknown
Not Applicable

Health and Aging Brain Study: Health Disparities Tau PET Scan Study

University of North Texas Health Science Center1 site in 1 country3,000 target enrollmentStarted: April 20, 2021Last updated:

Overview

Phase
Not Applicable
Enrollment
3,000
Locations
1
Primary Endpoint
Health Disparities in Aging

Overview

Brief Summary

The purpose of this project is to study the aging brain among participants enrolled in the Health and Aging Brain Study: Health Disparities project . There are a number of things that can influence how people think as they age, including diabetes, depression, as well as our biology. In this study, the investigators seek to study the aging brain by using brain PET scans that create detailed pictures of the brain.

Detailed Description

There are a number of things that can influence how we think as people age, including diabetes, depression, as well as our biology. In this study, the investigators are using PET scans with a tracer to create detailed pictures of the brain. This information will be used to help the investigators understand how the brain ages and in the future could be used to develop better diagnostics and treatments for Alzheimer's disease and memory loss in Mexican Americans, African Americans, and non-Hispanic whites. The goal of this study is to address this disparity by enrolling ethnically diverse participants in this study.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
50 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Enrolled in the Health and Aging Brain Study HD: Health Disparities project
  • Provided consent to re-contact
  • Willing and capable of undergoing PET scan of the head

Exclusion Criteria

  • Inability to provide informed consent by self or by proxy.
  • Pregnant or breast feeding women\*
  • History of alcoholism or drug dependency/abuse within the last 2 years before screening
  • Hypersensitivity to the active substance or to any of the following excipients is contraindicated: sodium dihydrogen phosphate, phosphoric acid, sodium ascorbate, ethanol (anhydrous), water for injection
  • Participants may not be in this study if they do not meet the safety criteria to undergo imaging procedures.

Outcomes

Primary Outcomes

Health Disparities in Aging

Time Frame: Through study completion in 2 years

Examine the prevalence of Tau burden among a multi ethnic cohort

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials